Arezou Khosrojerdi

648 total citations
31 papers, 458 citations indexed

About

Arezou Khosrojerdi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Arezou Khosrojerdi has authored 31 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Arezou Khosrojerdi's work include Immune Cell Function and Interaction (6 papers), Mesenchymal stem cell research (4 papers) and Immunotherapy and Immune Responses (4 papers). Arezou Khosrojerdi is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Mesenchymal stem cell research (4 papers) and Immunotherapy and Immune Responses (4 papers). Arezou Khosrojerdi collaborates with scholars based in Iran, Australia and United Kingdom. Arezou Khosrojerdi's co-authors include Sara Soudi, Mohammad Javan, Seyed Mohammad Moazzeni, Ahmad Zavaran Hosseini, Seyed Mahmoud Hashemi, Armita Mahdavi Gorabi, Saeed Aslani, Amirhossein Sahebkar, Thomas P. Johnston and Amir Abbas Momtazi‐Borojeni and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Arezou Khosrojerdi

30 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arezou Khosrojerdi Iran 13 208 125 63 58 51 31 458
Mengjia Hu China 13 237 1.1× 134 1.1× 55 0.9× 55 0.9× 58 1.1× 30 576
Marìa Albertina Romaniuk Argentina 11 248 1.2× 215 1.7× 79 1.3× 48 0.8× 78 1.5× 17 601
Lina Zhang China 13 209 1.0× 110 0.9× 48 0.8× 172 3.0× 60 1.2× 36 538
Yuanxin Sun China 13 175 0.8× 177 1.4× 48 0.8× 42 0.7× 54 1.1× 23 478
Agata Poniewierska-Baran Poland 13 217 1.0× 78 0.6× 58 0.9× 65 1.1× 41 0.8× 35 517
Giovanni Luca Scaglione Italy 16 308 1.5× 103 0.8× 29 0.5× 64 1.1× 62 1.2× 55 677
Jinwei Chen China 13 163 0.8× 133 1.1× 25 0.4× 49 0.8× 104 2.0× 40 627
Hongyan Qian China 15 182 0.9× 198 1.6× 18 0.3× 77 1.3× 35 0.7× 44 594
Haijin Lv China 9 278 1.3× 113 0.9× 93 1.5× 25 0.4× 98 1.9× 17 517
Marco De Zuani Czechia 13 117 0.6× 199 1.6× 17 0.3× 56 1.0× 66 1.3× 20 419

Countries citing papers authored by Arezou Khosrojerdi

Since Specialization
Citations

This map shows the geographic impact of Arezou Khosrojerdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arezou Khosrojerdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arezou Khosrojerdi more than expected).

Fields of papers citing papers by Arezou Khosrojerdi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arezou Khosrojerdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arezou Khosrojerdi. The network helps show where Arezou Khosrojerdi may publish in the future.

Co-authorship network of co-authors of Arezou Khosrojerdi

This figure shows the co-authorship network connecting the top 25 collaborators of Arezou Khosrojerdi. A scholar is included among the top collaborators of Arezou Khosrojerdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arezou Khosrojerdi. Arezou Khosrojerdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khosrojerdi, Arezou, et al.. (2025). From pathogen to cure: exploring the antitumor potential of Toxoplasma gondii. Infectious Agents and Cancer. 20(1). 39–39. 1 indexed citations
2.
Javan, Mohammad Reza, et al.. (2025). Mast cells in autoimmune disease: Unveiling their multifaceted roles and therapeutic potential. Human Immunology. 86(4). 111334–111334. 1 indexed citations
3.
Javan, Mohammad Reza, et al.. (2025). Immune escape in colorectal cancer: Mechanisms and challenges of immune checkpoint inhibitor resistance. International Immunopharmacology. 169. 115986–115986.
4.
5.
Khosrojerdi, Arezou, et al.. (2024). Exploring the Impact of Leishmania Major on Mesenchymal Stem Cells: Evaluating Differentiation, and Immunomodulatory Function. Iranian Journal of Allergy Asthma and Immunology. 22(6). 588–599. 1 indexed citations
6.
Khosrojerdi, Arezou, Mohammad Lotfollahi, Mohammad GhasemiGol, et al.. (2023). Single-cell RNA sequencing uncovers heterogeneous transcriptional signatures in tumor-infiltrated dendritic cells in prostate cancer. Heliyon. 9(5). e15694–e15694. 6 indexed citations
7.
Aslani, Saeed, Habib Zarredar, Mohammad Javan, et al.. (2023). The Epigenetic Contribution to the Pathogenesis of Psoriasis: Recent Advances. Current Medicinal Chemistry. 31(29). 4621–4639. 4 indexed citations
8.
Paydar, Shahram, et al.. (2023). Copeptin: a novel prognostic biomarker in trauma: a review article. Journal of Health Population and Nutrition. 42(1). 128–128. 4 indexed citations
9.
Khosrojerdi, Arezou, Mohammad Amin Honardoost, Nicola Silvestris, et al.. (2023). Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy. PLoS ONE. 18(12). e0295863–e0295863. 7 indexed citations
10.
Hazrati, Ali, Kosar Malekpour, Arezou Khosrojerdi, et al.. (2023). Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. Frontiers in Immunology. 14. 1280601–1280601. 12 indexed citations
11.
12.
Behrooz, Amir Barzegar, Arezou Khosrojerdi, Atefeh Zarepour, et al.. (2022). Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. Cancers. 14(15). 3698–3698. 14 indexed citations
13.
Tahmasebi, Safa, et al.. (2022). Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in a mouse model of LPS induced systemic inflammation. Life Sciences. 310. 120938–120938. 33 indexed citations
14.
Sohi, Alireza Naderi, et al.. (2021). Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque. Vaccines. 9(9). 1007–1007. 25 indexed citations
15.
Khosrojerdi, Arezou, Sara Soudi, Ahmad Zavaran Hosseini, & Seyed Mahmoud Hashemi. (2021). A New Approach to Monitoring and Evaluation of Cecal Ligation and Puncture Sepsis Model. 3(2). 97–106. 2 indexed citations
16.
Mohammadi, Fatemeh, Fatemeh Ezzatifar, Armita Mahdavi Gorabi, et al.. (2021). Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019. International Immunopharmacology. 100. 108076–108076. 31 indexed citations
17.
Khosrojerdi, Arezou, et al.. (2021). Imipenem alters systemic and liver inflammatory responses in CLP- induced sepsis mice in a dose-dependent manner. International Immunopharmacology. 93. 107421–107421. 11 indexed citations
18.
Khosrojerdi, Arezou, Saeed Aslani, Maryam Hemmatzadeh, et al.. (2021). Multi-facets of neutrophil extracellular trap in infectious diseases: Moving beyond immunity. Microbial Pathogenesis. 158. 105066–105066. 27 indexed citations
19.
Khosrojerdi, Arezou, Saeed Aslani, Danyal Imani, et al.. (2020). Matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of multiple sclerosis: systematic review and meta-analysis. BMC Neurology. 20(1). 218–218. 22 indexed citations
20.
Haftcheshmeh, Saeed Mohammadian, et al.. (2020). Immunomodulatory Effects of Curcumin in Rheumatoid Arthritis: Evidence from Molecular Mechanisms to Clinical Outcomes. Reviews of physiology, biochemistry and pharmacology. 179. 1–29. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengjia Hu Breakdown of academic impact, for papers by Marìa Albertina Romaniuk Breakdown of academic impact, for papers by Lina Zhang Breakdown of academic impact, for papers by Yuanxin Sun Breakdown of academic impact, for papers by Agata Poniewierska-Baran Breakdown of academic impact, for papers by Giovanni Luca Scaglione Breakdown of academic impact, for papers by Jinwei Chen Breakdown of academic impact, for papers by Hongyan Qian Breakdown of academic impact, for papers by Haijin Lv Breakdown of academic impact, for papers by Marco De Zuani
Rankless by CCL
2026